These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 7909438)
1. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides. Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation. Brysch W; Magal E; Louis JC; Kunst M; Klinger I; Schlingensiepen R; Schlingensiepen KH Cancer Gene Ther; 1994 Jun; 1(2):99-105. PubMed ID: 7621247 [TBL] [Abstract][Full Text] [Related]
3. A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells. Coulson JM; Poyner DR; Chantry A; Irwin WJ; Akhtar S Mol Pharmacol; 1996 Aug; 50(2):314-25. PubMed ID: 8700139 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway. Alper O; Hacker NF; Cho-Chung YS Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317 [TBL] [Abstract][Full Text] [Related]
6. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Ethier SP; Kokeny KE; Ridings JW; Dilts CA Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene. Yang DC; Jiang XP; Elliott RL; Head JF Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259 [TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Tari AM; Hung MC; Li K; Lopez-Berestein G Oncogene; 1999 Feb; 18(6):1325-32. PubMed ID: 10022814 [TBL] [Abstract][Full Text] [Related]
9. Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL. Smith MR; Abubakr Y; Mohammad R; Xie T; Hamdan M; al-Katib A Cancer Gene Ther; 1995 Sep; 2(3):207-12. PubMed ID: 8528964 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation. Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683 [TBL] [Abstract][Full Text] [Related]
11. Altered gene expression in drug-resistant human breast cancer cells. Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641 [TBL] [Abstract][Full Text] [Related]
12. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts. Ramachandran C; Wellham LL Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558 [TBL] [Abstract][Full Text] [Related]
13. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells. Yang DC; Jiang X; Elliott RL; Head JF Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831 [TBL] [Abstract][Full Text] [Related]
14. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Abdel-Mageed A; Agrawal KC Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939 [TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu. Roh H; Pippin J; Boswell C; Drebin JA J Surg Res; 1998 Jun; 77(1):85-90. PubMed ID: 9698539 [TBL] [Abstract][Full Text] [Related]
16. [The study of relationship between c-erbB2 expression and cytoimmunology in ovarian carcinoma and its antisense regulation]. Jin Z; Zhang X; Feng Y Zhonghua Fu Chan Ke Za Zhi; 1995 Apr; 30(4):222-4. PubMed ID: 7664609 [TBL] [Abstract][Full Text] [Related]
17. Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line: measurement of c-erbB2 mRNA half-life. Pasleau F; Grooteclaes M; Gol-Winkler R Oncogene; 1993 Apr; 8(4):849-54. PubMed ID: 8096075 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation. Cioffi CL; Garay M; Johnston JF; McGraw K; Boggs RT; Hreniuk D; Monia BP Mol Pharmacol; 1997 Mar; 51(3):383-9. PubMed ID: 9058592 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of TF gene expression by antisense oligonucleotides in different cancer cell lines. Förster Y; Schwenzer B J Exp Ther Oncol; 2004 Dec; 4(4):281-9. PubMed ID: 15844658 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides. Cucco C; Calabretta B Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]